Dedicated to solving complex drug delivery problems.
PhaseRx is developing novel polymeric vehicles for the delivery of macromolecular therapeutics, including siRNA. The Company’s proprietary technology is a new type of synthetic, multi-functional polymer exclusively licensed from the
University of Washington.